Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform


Out of Business LATEST DEAL TYPE

Owner and operator of a bio pharmaceutical company intended to offer therapeutics for neurologic, metabolic and oncologic diseases. The company bio pharmaceutical services include using proprietary technology for the development of drug products that cross the blood-brain barrier, enabling patients to avail treatment for neurologic, metabolic and oncologic diseases of the brain.

Ownership Status
Out of Business
Financing Status
Formerly Accelerator/Incubator backed
Primary Industry
Other Pharmaceuticals and Biotechnology
Other Industries
Drug Discovery
Primary Office
  • 6020 Cornerstone West Court
  • Suite 200
  • San Diego, CA 92121
  • United States
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore NeuroTransit’s full profile, request a free trial.

NeuroTransit Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business Completed Out of Business
2. Early Stage VC 01-Jan-2013 Completed Startup
1. Accelerator/Incubator Completed Startup
To view this company’s complete deal history including valuation and funding, request access »

NeuroTransit Executive Team (2)

Name Title Board
Michael Dunn Co-Founder, President and Chief Executive Officer

1 Former Executive

You’re viewing 1 of 2 executives. Get the full list »